Skip to main content
. Author manuscript; available in PMC: 2012 Jan 1.
Published in final edited form as: Am J Kidney Dis. 2011 Jan;57(1):101–112. doi: 10.1053/j.ajkd.2010.08.021

Table 3.

Univariate and Case-Mix–Adjusted Regression Analysis of Physical Health Composite Score

Univariate
Case-Mix–Adjusted
Variables No. Estimate (95% CI) P Estimate (95% CI) P
Age (/decade) 375
≤50 y −2.56 (−4.02 to −1.10) <0.001 −2.65 (−4.11 to −1.19) <0.001
>50 y 1.59 (0.19 to 2.99) 0.03 1.69 (0.28 to 3.09) 0.02
Male 375 1.90 (−0.21 to 4.01) 0.08 2.12 (0.03 to 4.21) 0.05
Black race 375 −0.08 (−2.20 to 2.04) 0.9 0.48 (−1.62 to 2.59) 0.7
ESRD vintage (/1 y) 375 0.15 (−0.02 to 0.32) 0.08 0.17 (0.001 to 0.34) 0.05
Primary language not English 375 2.72 (−0.02 to 5.47) 0.05 2.94 (0.09 to 5.80) 0.04
Education levela 372
 <High school graduate 1.06 (−1.69 to 3.80) 0.5 0.61 (−2.14 to 3.36) 0.7
 High school graduate 0.26 (−2.29 to 2.80) 0.8 0.20 (−2.32 to 2.72) 0.9
Does not live with family 372 1.16 (−1.19 to 3.50) 0.3 1.23 (−1.13 to 3.60) 0.3
Insurance statusb 372
 Employer group health insurance or privately
  purchased
0.39 (−2.24 to 3.02) 0.8 0.53 (−2.07 to 3.14) 0.7
 Government insurance for the poorc 0.22 (−2.27 to 2.71) 0.9 0.28 (−2.24 to 2.80) 0.8
Diabetes 370 −4.55 (−6.60 to −2.49) <0.001 −4.11 (−6.27 to −1.95) <0.001
Congestive heart failure 370 −3.46 (−6.10 to −0.82) 0.01 −3.16 (−5.86 to −0.46) 0.02
Peripheral arterial disease 370 −5.77 (−8.89 to −2.65) <0.001 −6.04 (−9.19 to −2.89) <0.001
Stroke 370 −5.17 (−9.20 to −1.14) 0.01 −4.48 (−8.51 to −0.44) 0.03
enPCR (/0.1 g/kg/d) 371 0.36 (−0.01 to 0.74) 0.06 0.48 (0.09 to 0.86) 0.01
Residual renal clearance (/1 mL/min)d 372
 Randomized patients 8.74 (0.04 to 5.72) 0.04 8.29 (0.02 to 5.61) 0.04
 Not randomized patients 0.05 (−1.80 to 1.79) 0.8 0.06 (−1.80 to 1.81) 0.8
Creatinine (/1 mg/dL) 372 0.61 (0.26 to 0.95) <0.001 0.63 (0.24 to 1.01) 0.002
Phosphate (/1 mg/dL) 372 0.20 (−0.41 to 0.82) 0.5 0.24 (−0.39 to 0.87) 0.5
Hemoglobin (/1 g/dL) 346 0.71 (−0.13 to 1.55) 0.1 0.63 (−0.19 to 1.46) 0.1
PTH (/0.1 pg/L) 364 1.85 (−0.44 to 13.4) 0.2 0.26 (0.001 to 0.53) 0.05
Albumin (/1 g/dL)d 372
 Daily Trial 0.56 (0.27 to 0.85) <0.001 0.56 (0.27 to 0.85) <0.001
 Nocturnal Trial 0.02 (−0.39 to 0.42) 0.9 −0.05 (−0.45 to 0.36) 0.8
Calcium (/1 mg/dL) 364 0.78 (−0.40 to 1.96) 0.2 1.09 (−0.09 to 2.28) 0.07
Bicarbonate (/1 mmol/L) 363 −0.06 (−0.34 to 0.21) 0.6 −0.07 (−0.35 to 0.20) 0.6
LV mass (/10 g) 349 −0.04 (−0.25 to 0.16) 0.7 −0.13 (−0.35 to 0.10) 0.3
BMI (/1 kg/m2) 353 −0.13 (−0.27 to 0.01) 0.07 −0.10 (−0.24 to 0.04) 0.2
ICW volume/weight (/1 dL/kg) 351 2.53 (0.87 to 4.20) 0.003 3.53 (0.72 to 6.33) 0.01
Phase angle (/0.1°) 351 0.07 (−0.01 to 0.14) 0.07 0.05 (−0.03 to 0.13) 0.2
Randomly assigned 375 4.43 (1.38 to 7.48) 0.005 4.30 (1.29 to 7.31) 0.005
Nocturnal trial 375 −0.89 (−3.26 to 1.47) 0.5 −0.90 (−3.26 to 1.46) 0.5

Note: The physical health composite score is a weighted average of scores deriving from 8 scales of self-reported health status: Physical Functioning, Role-Physical, Bodily Pain, General Health, Vitality, Social Functioning, and Role-Emotional, scored 0-100.

Abbreviations: BMI, body mass index; CI, confidence interval; enPCR, equilibrated normalized protein catabolic rate; ESRD, end-stage renal disease; ICW, intracellular water; LV, left ventricular; PTH, parathyroid hormone.

a

The reference group is individuals with education beyond high school.

b

The reference group is government insurance not awarded by income level (Medicare plus Canadian Health).

c

Medicaid and/or other state/county programs.

d

Variables showed a statistically significant interaction with trial or randomization status.